Physician profile
Andrew D Neeb
NPI 1225064421
$8,750.22
in general payments reported to CMS, 2019-2025
41 companies · $865 in 2025
The $865 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,132 · 2020: $411 · 2021: $313 · 2022: $531 · 2023: $1,509 · 2024: $1,989 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,753 · Travel and Lodging: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,752.93 |
| Travel and Lodging | $610.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,185.24 | 2019-2020 | |
| Teleflex LLC | $1,281.20 | 2021-2024 | Urolift |
| Coloplast Corp | $806.56 | 2019-2025 | |
| Boston Scientific Corporation | $726.88 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Moses |
| Edap Technomed INC | $700.63 | 2023-2024 | |
| Abbvie INC. | $324.96 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $308.04 | 2019-2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $229.88 | 2019-2023 | Provenge |
| Procept Biorobotics Corporation | $209.12 | 2019-2024 | Aquabeam System |
| Innovation Technologies INC | $190.77 | 2023 | Irrisept |
| Astellas Pharma US INC | $174.10 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $171.74 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $169.48 | 2021-2025 | Prolaris, Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $138.91 | 2020-2025 | |
| Tolmar, INC. | $129.03 | 2023-2025 | Jatenzo, Eligard |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Neeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.